Insulet Corporation (NASDAQ:PODD) Q4 2023 Earnings Call Transcript February 22, 2024 Insulet Corporation beats earnings expectations. Reported EPS is $1.44, expectations were $0.67. Insulet Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome […]
Insulet CFO to step down wbjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wbjournal.com Daily Mail and Mail on Sunday newspapers.
Reaffirms Guidance for Third Quarter and Fiscal Year 2023ACTON, Mass. (BUSINESS WIRE) Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Wayde McMillan has decided to step down from his role as.